No profile data available.
Medicamen Biotech Limited (MEDICAMEQ.NS) is a healthcare company in the drug manufacturing contractors industry, based in New Delhi, India, with about 405 full-time employees.
It reported revenue of 1.63 billion INR for fiscal year 2025, down 9.3% from fiscal year 2024, and net income of 71.08 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 469.09 million INR, up 3.9% from a year before. Its market capitalization was 4.08 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, and sells pharmaceutical formulations in India and internationally. The company provides tablets, capsules, dry syrups, oral liquids, ointments, and other pharmaceutical dosage forms.
Medicamen Biotech reported 1.63 billion INR in revenue for fiscal year 2025, down 9.3% from 1.79 billion INR in fiscal year 2024. In Q3 2026 revenue was 469.09 million INR.
4.08 billion INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include ZIM Laboratories Limited (ZIMLAB.NS), Wanbury Limited (WANBURY.NS), Haleos Labs Limited (SMSLIFE.BO), Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS).